Mattern Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Mattern Capital Management's AMGN Position: Q2 2026 in Review
Mattern Capital Management increased its Amgen (AMGN) stake by 17% in Q2 2026, buying an estimated $1.41M and bringing the position to 28,008 shares worth $10.1M. The position accounts for 1.18% of the portfolio, ranked #36.
Mattern Capital Management first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $11.3M in Q4 2025. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Mattern Capital Management held 28,008 shares of Amgen worth $10.1M as of Q2 2026.
- Mattern Capital Management bought 4,118 Amgen shares in Q2 2026, an estimated $1.41M.
- Amgen made up 1.18% of Mattern Capital Management's portfolio in Q2 2026, its #36 holding.
- Mattern Capital Management first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- Mattern Capital Management's Amgen position peaked at $11.3M in Q4 2025.
- 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Mattern Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.